Edward Silverman | Nov 15, 1987 | 4 min read
NEW YORK—Venture capitalist William J. Kane remembers “Flex Infusion Inc.” all too well. He spent nearly 40 hours investigating the nascent company’s product, people and plans—and then didn’t invest a dime. “We liked what we saw, got good feedback on the attractiveness of their technology and the potential of the applications,” said Kane, 31, a senior associate at Harvest Ventures Inc. here. "But we were still uncomfortable with the rate of gr